American Journal of Kidney Diseases
Volume 49, Issue 6 , Page 873 , June 2007

C-Reactive Protein Level in Dialysis Patients: Weak Genetic Influence and Nonspecific Clinical Meaning

  • George Tsirpanlis, MD

      Affiliations

    • Department of Nephrology, General Hospital of Athens, Athens, Greece
    • ,
  • Christiana Petrihou, MD

      Affiliations

    • Department of Nephrology, General Hospital of Athens, Athens, Greece
    • ,
  • Konstantina Tsiolaki, MD

      Affiliations

    • Department of Nephrology, General Hospital of Athens, Athens, Greece
    • ,
  • George Triantafyllis, MD

      Affiliations

    • Department of Nephrology, General Hospital of Athens, Athens, Greece
    • ,
  • Eleni Sakka, MD

      Affiliations

    • Department of Nephrology, General Hospital of Athens, Athens, Greece
    • ,
  • Stylianos Chatzipanagiotou, MD

      Affiliations

    • Department of Medical Biopathology, Eginition Hospital, Medical School, University of Athens, Athens, Greece

References 

  1. Zhang L, Kao L, Berthier-Schaad Y, et al. C-Reactive protein haplotype predicts C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis. 2007;49:118–126
  2. Tsirpanlis G, Bagos P, Ioannou D, et al. The variability and accurate assessment of microinflammation in hemodialysis patients. Nephrol Dial Transplant. 2004;19:150–157
  3. Kaysen GA, Dubin JA, Muller HG, et al. The acute phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int. 2000;58:346–352
  4. Tsirpanlis G, Chatzipanagiotou S, Ioannidis A, et al. The effect of viable Chlamydia pneumoniae on serum cytokines and adhesion molecules in hemodialysis patients. Kidney Int Suppl. 2003;84:S72–S75
  5. Tsirpanlis G, Bagos P, Ioannou D, et al. Exploring inflammation in hemodialysis patients: Persistent and superimposed inflammation. Kidney Blood Press Res. 2004;27:63–70
  6. Tsirpanlis G. The pattern of inflammation and a potential new clinical meaning and usefulness of C-reactive protein in end-stage renal failure patients. Kidney Blood Press Res. 2005;28:55–61
  7. Danesh J, Wheeler JG, Hirschfield GM, et al. C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–1397
  8. Lowe GD, Pepys MB. C-Reactive protein and cardiovascular disease: Weighing the evidence. Curr Atheroscler Rep. 2006;8:421–428
  9. Tsirpanlis G. Inflammation in atherosclerosis and other conditions: A response to danger. Kidney Blood Press Res. 2005;28:211–217

PII: S0272-6386(07)00652-X

doi: 10.1053/j.ajkd.2007.03.016

American Journal of Kidney Diseases
Volume 49, Issue 6 , Page 873 , June 2007

Article Tools